Stay updated on Eplontersen in ATTR CM: Clinical Trial
Sign up to get notified when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.

Latest updates to the Eplontersen in ATTR CM: Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.5.3 was added, replacing v3.5.2, indicating a minor editorial update to the page. The change records a new version of the page, reflecting maintenance adjustments rather than content changes.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedPublication information was added: a PubMed-listed study citation appears under Publications with automatic PubMed sourcing. The revision history was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is an administrative version update with no visible alterations to study details.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.4.3 is now shown on the page, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded the topic tag 'Amyloidosis' and a new resource entry for the Genetic and Rare Diseases Information Center on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check86 days agoChange DetectedNon-significant site-wide updates including Revision: v3.4.2 and the removal of a government funding notice; these changes do not affect trial details or study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Eplontersen in ATTR CM: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eplontersen in ATTR CM: Clinical Trial page.